Highly attenuated recombinant vesicular stomatitis virus VSV-12'GFP displays immunogenic and oncolytic activity
about
Harnessing the immune system to improve cancer therapyUnderstanding and altering cell tropism of vesicular stomatitis virusChikungunya, Influenza, Nipah, and Semliki Forest Chimeric Viruses with Vesicular Stomatitis Virus: Actions in the BrainType III interferon attenuates a vesicular stomatitis virus-based vaccine vector.EXPLORING THE ANTITUMOR EFFECT OF VIRUS IN MALIGNANT GLIOMAMurine Tumor Models for Oncolytic Rhabdo-Virotherapy.Vesicular stomatitis virus variants selectively infect and kill human melanomas but not normal melanocytesLong-distance interferon signaling within the brain blocks virus spread.Lassa-vesicular stomatitis chimeric virus safely destroys brain tumorsA mathematical approach to virus therapy of glioblastomas.Attenuation of vesicular stomatitis virus infection of brain using antiviral drugs and an adeno-associated virus-interferon vector.Recent advances in vesicular stomatitis virus-based oncolytic virotherapy: a 5-year update.Nose-to-Brain Delivery of Antiviral Drugs: A Way to Overcome Their Active Efflux?Oncotargeting by Vesicular Stomatitis Virus (VSV): Advances in Cancer Therapy.Immunogenicity in African Green Monkeys of M Protein Mutant Vesicular Stomatitis Virus Vectors and Contribution of Vector-Encoded Flagellin.New Vaccine Technologies to Combat Outbreak Situations
P2860
Q26738698-572A13F1-9C7D-4120-838E-D80679989849Q27687067-6889CA8C-6A44-4258-A400-26CA7F4CCDDAQ28223031-F4774890-177C-4ADE-B9C5-9CA935E362A1Q34262131-325BDFF0-84FD-4BD6-992E-8C93F2047205Q36549443-3C0FBB25-2347-43A9-AFF5-ACB71EE02720Q36751597-A3CD0165-580F-4AE3-B238-BC912A01D0ECQ36911654-6F43A542-C474-4582-B4BA-ADE344D58B3DQ38309724-2CF8B6ED-2FE0-46AD-80E1-EA9305247A14Q38886667-3B033214-551E-41A2-941D-657845C8E129Q38923793-982C168E-2F27-4883-A335-FAA4C2754ADCQ41625843-02860414-3738-46C6-B8BF-2D4E4B16B324Q45324769-265FC07E-07FB-4EE6-B21C-2170BE7277CFQ52627559-A9D1504E-20FA-4CBC-A27D-8A95A56A4E4CQ52688581-6C1D8805-9AE3-418F-BFB7-8747CA4EE34CQ53699705-1D1F5F08-4B37-48CA-9ABA-C3DD1D30F980Q57072744-7A901FA4-3D8C-43CE-846A-A351828BD21C
P2860
Highly attenuated recombinant vesicular stomatitis virus VSV-12'GFP displays immunogenic and oncolytic activity
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Highly attenuated recombinant ...... nogenic and oncolytic activity
@en
type
label
Highly attenuated recombinant ...... nogenic and oncolytic activity
@en
prefLabel
Highly attenuated recombinant ...... nogenic and oncolytic activity
@en
P2860
P356
P1433
P1476
Highly attenuated recombinant ...... nogenic and oncolytic activity
@en
P2093
Anthony N van den Pol
John N Davis
P2860
P304
P356
10.1128/JVI.01106-12
P407
P577
2012-11-07T00:00:00Z